Advanced Filters
noise

Isleworth, United Kingdom Clinical Trials

A listing of Isleworth, United Kingdom clinical trials actively recruiting patients volunteers.

Found 672 clinical trials

Fosfomycin i.v. for Treatment of Severely Infected Patients

The purpose of this European, multicentric, prospective, non-interventional study is to document and evaluate the efficacy and safety of the treatment of severely infected patients with intravenously administered fosfomycin, including patients with osteomyelitis, complicated urinary tract infection, nosocomial lower respiratory tract infection, bacterial meningitis/central nervous system infection, bacteraemia/sepsis, skin and …

18 years of age All Phase N/A
O Orla Mitchell

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

PD Frontline (part of RAPSODI GD) is an online study observational study with the goal of bringing People with Parkinson's to the frontline of research by getting them trial ready. To do this, participants are offered genetic sequencing for the GBA and LRRK2 gene with an at-home saliva collection kit.

18 - 90 years of age All Phase N/A

International Wilson's Disease Patient Registry (iWilson Registry)

Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a …

12 years of age All Phase N/A
S Silvia Novello, MD

Met Non Small Cell Cancer Registry (MOMENT)

The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, …

years of age All Phase N/A
N Nikoloz Chkhartishvili, MD

The RESPOND Outcomes Study

The RESPOND Outcomes study is a research study around use of antiretroviral and other relevant drugs and long-term clinical outcomes in patients living with HIV. Data collected in this study will be used to answer key unanswered questions regarding treatment of people living with HIV.

18 years of age All Phase N/A

Tendyne European Experience Registry

TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.

18 years of age All Phase N/A
S Sarah Gibbon

Study of Late-foetal Human Organ Development

Knowledge about abnormal organ development is important to understand pathology and to develop novel treatment approaches for individuals with congenital and acquired disease. Most of our current understanding is based on examination of tissues from the embryo and early fetus, collected from women undergoing termination of pregnancy in the first …

18 years of age All Phase N/A
L Lead Research officer

Vulvar Disease in Nigeria Observational Study

Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

10 - 90 years of age Female Phase N/A
M Matthew Krebs, Prof

Tumour Characterisation to Guide Experimental Targeted Therapy - National

The primary aim of TARGET National is to establish a national framework to offer molecular profiling of circulating tumour DNA and/or tumour tissue (optional) to patients with advanced solid cancers referred to any of the Experimental Cancer Medicine Centres (ECMCs) across the UK, in order to help decision making for …

16 years of age All Phase N/A

SCOOT: Sample Collection for DART

The study will use a blood sample collected from participants to: Develop new ways of finding and diagnosing lung health problems, such as lung cancer. Develop tools which make it easier to screen people with possible lung health problems, diagnose problems earlier and with fewer tests, and start the best …

55 - 75 years of age All Phase N/A

Simplify language using AI